A multicentre double‐blind, double‐dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients-Reference-Cited by-同舟云学术

A multicentre double‐blind, double‐dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients

Published:2021-09-16 Issue:5 Volume:195 Page:781-789
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mei Heng¹²³^ORCID,Xu Min¹,Yuan Guolin⁴,Zhu Feiyue⁵,Guo Jingming⁶,Huang Ruibin⁷,Qin Jun⁸,Lv Tingting⁴,Qin Fangmei⁵,Cai Huili⁶,Yin Ping⁹,Qin Tingting⁹,Hu Yu¹²³^ORCID

Affiliation:

1. Institute of Haematology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

2. Hubei Clinical and Research Center of Thrombosis and Hemostasis Wuhan Hubei China

3. Collaborative Innovation Center of Hematology Huazhong University of Science and Technology Wuhan HubeiChina

4. Department of Hematology Xiangyang Central Hospital Affiliated Hospital of Hubei University of Arts and Science Xiangyang HubeiChina

5. Institute of Haematology Loudi Central Hospital Loudi HunanChina

6. Institute of Haematology Yichang Central People’s Hospital Yichang HubeiChina

7. Institute of Haematology The First Affiliated Hospital of Nanchang University Nanchang JiangxiChina

8. Institute of Haematology People’s Hospital Shiyan HubeiChina

9. Department of Epidemiology & Statistics School of Public Health Tongji Medical College Huazhong University of Science & Technology Wuhan Hubei China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17808

Reference29 articles.

1. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro

2. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura

3. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports

4. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review

5. Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study;Hematology;2023-12-29

2. Current status and cost burden of non-first-line treatment in ITP: A multicenter study based on real-world data in China;Intelligent Pharmacy;2023-12

3. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia;Platelets;2023-11-08

4. Hetrombopag plus recombinant human thrombopoietin for chemotherapy-induced thrombocytopenia in patients with solid tumors;Research and Practice in Thrombosis and Haemostasis;2023-10

5. Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients;Pharmaceuticals;2023-08-29